S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A. (12th March 2014)

Record Type:
Journal Article
Title:
S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A. (12th March 2014)
Main Title:
S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
Authors:
Cha, E
Abstract:
Is Part Of:
Journal for immunotherapy of cancer. Volume 2(2014)Supplement 2
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 2
Issue Display:
Volume 2, Issue 2 (2014)
Year:
2014
Volume:
2
Issue:
2
Issue Sort Value:
2014-0002-0002-0000
Page Start:
Page End:
Publication Date:
2014-03-12
Subjects:
Melanoma -- Adaptive Immune Response -- Clinical Activity -- Tumor Specimen -- Human Monoclonal Antibody
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:
http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:
10.1186/2051-1426-2-S2-I21 ↗
Languages:
English
ISSNs:
2051-1426
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
19198.xml